Desensitisation to subcutaneous insulin using CSII followed by i-Port Advance™
DOI:
https://doi.org/10.15277/bjd.2017.116References
Moyes V, Driver R, Croom A, Mirakian,R, Chowdhury TA. Insulin allergy in a patient with type 2 diabetes successfully treated with continuous subcutaneous insulin infusion. Diabet Med 2006;23:204-06. https://doi.org/10.1111/j.1464-5491.2006.01811.x
Vervloet D, Pradal M, Birnbaum J, Koeppel M-C. Drug Allergy. Fourth Edition. Phadia AB, 2009, 322-4. http://www.phadia.com/PageFiles/ 27357/Drug-Book-web.pdf
Nagai T, Nagai Y, Tomizawa T, Mori M. Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion. Intern Med 1997;36:575-8. https://doi.org/10.2169/internalmedicine.36.575
Pratt EJ, Miles P, Kerr D. Localized insulin allergy treated with continuous subcutaneous insulin. Diabet Med 2001;18:515-16. https://doi.org/10.1046/j.1464-5491.2001.00454-2.x
Sola-Gazagnes A, Pecquet C, Radermecker R, et al. Successful treatment of insulin allergy in a type 1 diabetic patient by means of constant subcutaneous pump infusion of insulin. Diabetes Care 2003;26:2961-2. https://doi.org/10.2337/diacare.26.10.2961
Fujikawa T, Imbe H, Date M, Go Y, Kitaoka H. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion. Diabetes Res Clin Pract 2012;97:e31-3. https://doi.org/10.1016/j.diabres.2012.04.027
Published
Issue
Section
License
Publish & Transfer of Copyright Agreement
For the mutual benefit and protection of the Author and the Journal Owner/Publisher it is necessary that the Author provides formal written Consent to Publish and Transfer of Copyright before publication of the Work.
